Charles River Laboratories International (CRL)

Add to Watchlists Create an Alert
44.39 +0.04  +0.09%   NYSE May 24, 8:00PM BATS Real time Currency in USD

Charles River Laboratories International Shareholders Equity:

628.28M for March 31, 2013
View Full Chart

Charles River Laboratories International Shareholders Equity Chart

    Charles River Laboratories International Historical Shareholders Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 628.28M
    Dec. 31, 2012 600.80M
    Sept. 30, 2012 597.71M
    June 30, 2012 562.84M
    March 31, 2012 552.60M
    Dec. 31, 2011 525.58M
    Sept. 30, 2011 539.71M
    June 30, 2011 589.09M
    March 31, 2011 562.92M
    Dec. 31, 2010 687.42M
    Sept. 30, 2010 1.041B
    June 30, 2010 1.396B
    March 31, 2010 1.386B
    Dec. 31, 2009 1.375B
    Sept. 30, 2009 1.350B
    June 30, 2009 1.284B
    March 31, 2009 1.218B
    Dec. 31, 2008 1.199B
    Sept. 30, 2008 1.947B
    June 30, 2008 1.946B
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Shareholders' Equity

    Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
    Learn More

    Get data for

    CRL Shareholders Equity Benchmarks

    Companies
    Covance 1.343B
    Parexel International Corporation 551.92M
    Bioanalytical Systems 9.791M

    CRL Shareholders Equity Rankings

    Overall 77th percentile
    1701 of 7600
    Sector 82nd percentile
    115 of 653 in Healthcare
    Industry 78th percentile
    13 of 61 in Diagnostics & Research

    CRL Shareholders Equity Range, Past 5 Years

    Minimum 525.58M Dec 2011
    Maximum 1.947B Sep 2008
    Average 999.47M